Cinnamoyl-N-Acylhydrazone-Donepezil Hybrids: Synthesis and Evaluation of Novel Multifunctional Ligands Against Neurodegenerative Diseases

Neurochem Res. 2020 Dec;45(12):3003-3020. doi: 10.1007/s11064-020-03148-2. Epub 2020 Oct 20.

Abstract

A new series of ten multifunctional Cinnamoyl-N-acylhydrazone-donepezil hybrids was synthesized and evaluated as multifunctional ligands against neurodegenerative diseases. The molecular hybridization approach was based on the combination of 1-benzyl-4-piperidine fragment from the anti-Alzheimer AChE inhibitor donepezil (1) and the cinnamoyl subunit from curcumin (2), a natural product with remarkable antioxidant, neuroprotective and anti-inflammatory properties, using a N-acylhydrazone fragment as a spacer subunit. Compounds 4a and 4d showed moderate inhibitory activity towards AChE with IC50 values of 13.04 and 9.1 µM, respectively. In addition, compound 4a and 4d showed a similar predicted binding mode to that observed for donepezil in the molecular docking studies. On the other hand, compounds 4a and 4c exhibited significant radical scavenging activity, showing the best effects on the DPPH test and also exhibited a significant protective neuronal cell viability exposed to t-BuOOH and against 6-OHDA insult to prevent the oxidative stress in Parkinson's disease. Similarly, compound 4c was capable to prevent the ROS formation, with indirect antioxidant activity increasing intracellular GSH levels and the ability to counteract the neurotoxicity induced by both OAβ1-42 and 3-NP. In addition, ADMET in silico prediction indicated that both compounds 4a and 4c did not show relevant toxic effects. Due to their above-mentioned biological properties, compounds 4a and 4c could be explored as lead compounds in search of more effective and low toxic small molecules with multiple neuroprotective effects for neurodegenerative diseases.

Keywords: Cinnamoyl-N-acylhydrazone-donepezil hybrids MTDLs; Molecular hybridization; Multifunctional ligands; Neurodegenerative diseases.

MeSH terms

  • Acetylcholinesterase / metabolism
  • Butyrylcholinesterase / metabolism
  • Cell Line, Tumor
  • Cholinesterase Inhibitors / chemical synthesis
  • Cholinesterase Inhibitors / metabolism
  • Cholinesterase Inhibitors / pharmacokinetics
  • Cholinesterase Inhibitors / pharmacology
  • Cinnamates / chemical synthesis
  • Cinnamates / metabolism
  • Cinnamates / pharmacokinetics
  • Cinnamates / pharmacology*
  • Donepezil / chemical synthesis
  • Donepezil / metabolism
  • Donepezil / pharmacokinetics
  • Donepezil / pharmacology*
  • Free Radical Scavengers / chemical synthesis
  • Free Radical Scavengers / metabolism
  • Free Radical Scavengers / pharmacokinetics
  • Free Radical Scavengers / pharmacology
  • Humans
  • Hydrazones / chemical synthesis
  • Hydrazones / metabolism
  • Hydrazones / pharmacokinetics
  • Hydrazones / pharmacology*
  • Ligands
  • Molecular Docking Simulation
  • Molecular Structure
  • Neurodegenerative Diseases / drug therapy*
  • Neuroprotective Agents / chemical synthesis
  • Neuroprotective Agents / metabolism
  • Neuroprotective Agents / pharmacokinetics
  • Neuroprotective Agents / pharmacology*
  • Protein Binding
  • Structure-Activity Relationship

Substances

  • Cholinesterase Inhibitors
  • Cinnamates
  • Free Radical Scavengers
  • Hydrazones
  • Ligands
  • Neuroprotective Agents
  • Donepezil
  • Acetylcholinesterase
  • Butyrylcholinesterase